2306
H.-L. Kwong, W.-S. Lee / Tetrahedron: Asymmetry 11 (2000) 2299±2308
(CDCl3): ꢀ 18.28, 20.93, 26.31, 28.59, 38.85, 41.39, 46.71, 47.09, 117.62, 119.79, 133.22, 137.30,
141.78, 153.30, 155.57, 159.79; positive ion FAB mass spectra m/z: 450 (M++H). Anal calcd for
C31H35N3: C, 82.81; H, 7.85; N, 9.35. Found: C, 82.65; H, 7.58; N, 9.03.
3.6.2. Terpyridine 6
The above procedure was followed using isopropyl iodide. After workup and puri®cation by
column chromatography with petroleum ether:EtOAc (80:1, Rf=0.3), 0.22 g (57%) of terpyridine
6 was obtained: ꢁ2D5=+28.9 (c 0.50, CHCl3); IR (KBr): 2954.2 vs, 2931.3 vs, 2870.2 s, 1558.1 vs,
1428.6 vs; 1H NMR (CDCl3): ꢀ 0.66 (s, 6H), 0.89 (d, 6H, J=6.9 Hz), 1.20±1.70 (m, 2H), 1.27 (d,
6H, J=6.9 Hz), 1.41 (d, 2H), 1.44 (s, 6H), 2.40 (m, 2H), 2.60 (m, 2H), 2.79 (t, 2H, J=5.4 Hz),
2.93 (m, 2H), 7.35 (d, 2H, J=7.8 Hz), 7.90 (t, 1H, J=7.8 Hz), 8.34 (d, 2H, J=7.8 Hz), 8.44 (d,
2H, J=7.8 Hz); 13C NMR (CDCl3): ꢀ 20.21, 21.06, 22.37, 26.37, 29.33, 30.37, 41.39, 41.86, 46.74,
49.08, 117.47, 119.80, 133.23, 137.28, 142.26, 153.03, 155.68, 158.42; positive ion FAB mass
spectra m/z: 506 (M++H). Anal calcd for C35H43N3: C, 83.12; H, 8.57; N, 8.31. Found: C, 83.28;
H, 8.43; N, 8.08.
3.6.3. Terpyridine 7
The above procedure was followed using n-butyl iodide. After workup and puri®cation by
column chromatography with petroleum ether:EtOAc (80:1, Rf=0.3), 0.22 g (54%) of terpyridine
7 was obtained: ꢁ2D5=+25.9 (c 0.51, CHCl3); IR (KBr): 2954.2 vs, 2931.3 vs, 2862.6 s, 1558.1 vs,
1
1432.4 vs; H NMR (CDCl3): ꢀ 0.60±1.60 (18H), 0.67 (s, 6H), 1.34 (d, 2H, J=9.6 Hz), 1.45 (s,
6H), 2.39 (m, 2H), 2.56 (m, 2H), 2.81 (t, 2H, J=5.4 Hz), 3.06 (m, 2H), 7.34 (d, 2H, J=8.1 Hz),
7.92 (t, 1H, J=7.8 Hz), 8.31 (d, 2H, J=7.5 Hz), 8.45 (d, 2H, J=7.8 Hz); 13C NMR (CDCl3): ꢀ
14.23, 20.96, 23.02, 28.43, 29.69, 30.14, 32.24, 41.02, 43.33, 44.21, 46.86, 117.50, 119.78, 133.16,
137.31, 141.4, 153.19, 155.58, 159.47; positive ion FAB mass spectra m/z: 534 (M++H). Anal calcd
for C37H47N3: C, 83.25; H, 8.87; N, 7.87. Found: C, 83.09; H, 8.80; N, 7.65.
3.6.4. Terpyridine 8
The above procedure was followed using benzyl iodide. After workup and puri®cation by column
chromatography with petroleum ether:EtOAc (80:1, Rf=0.3), 0.18 g (39%) of terpyridine 8 was
obtained: ꢁ2D5=^94.8 (c 0.25, CHCl3); IR (KBr): 2977.1 s, 2916.0 vs, 2862.6 s, 1558.1 vs, 1428.6
vs; 1H NMR (CDCl3): ꢀ 0.64 (s, 6H), 1.36 (s, 6H), 1.46 (d, 2H, J=9.9 Hz), 2.14 (m, 2H), 2.59 (m,
2H), 2.78 (m, 4H), 3.41 (m, 2H), 3.89 (m, 2H), 7.34 (m, 5H), 7.40 (d, 2H, J=7.5 Hz), 7.94 (t, 1H,
J=8.1 Hz, J=7.8 Hz), 8.37 (d, 2H, J=7.5 Hz), 8.50 (d, 2H, J=8.1 Hz); 13C NMR (CDCl3): ꢀ
20.88, 26.26, 28.26, 38.71, 41.09, 42.45, 46.19, 46.85, 117.86, 119.91, 125.58, 128.07, 129.14,
133.41, 137.36, 140.98, 141.97, 153.24, 155.49, 158.23; positive ion FAB mass spectra m/z: 602
(M++H). Anal calcd for C43H43N3: C, 85.82; H, 7.20; N, 6.98. Found: C, 85.28; H, 7.10; N, 6.65.
3.7. Procedure for copper-catalyzed cyclopropanation
To a two-neck round-bottomed ¯ask were added Cu(OTf)2 (0.072 g, 0.02 mmol), CH2Cl2 (2.0
ml) and ligand (0.022 mmol) under nitrogen. The solution was stirred at room temperature for 2
h. Alkene (4 mmol) and diazoacetate (0.2 mmol) were then added and the mixture was stirred at
room temperature for a further 0.5 h. A solution of diazoacetate (1 mmol) in CH2Cl2 (0.5 ml) was
then added to the reaction mixture over a period of 4 h using a syringe pump. After the addition
of diazoacetate, the mixture was stirred for 16 h at room temperature. The mixture was then